National  Health Information Center 

Health Information Resource Database

[Inclusion of an information resource in this database does not imply endorsement
by the U.S. Department of Health and Human Services.]


Office of Orphan Products Development, U.S. Food and Drug Administration


Contact Information

Information
WO32-5271
10903 New Hampshire Avenue
Silver Spring, MD 20993-0002

1-800-300-7469 (Voice - Toll-free),
301-796-8660 (Voice),
301-847-8621 (FAX),

Internet Resources


Abstract

The FDA's Office of Orphan Products Development (OOPD) is dedicated to promoting the development of products that demonstrate promise for the diagnosis and/or treatment of rare diseases or conditions. To locate such products, the OOPD interacts with the medical and research communities, professional organizations, academia, and the pharmaceutical industry, as well as rare disease groups. The OOPD administers the major provisions of the Orphan Drug Act (ODA) which provide incentives for sponsors to develop products for rare diseases. More than 228 drugs and biological products for rare diseases have been brought to market since 1983.

Publications


Keywords

You may search for other related entries in the database under the following topics.


Notes

816.11: New address and phone numbers. AR

Audit

Date Entered: 7/1/1997
Date Edited: 3/28/2013
Date Revised: 1/3/2002
Health Referral Number: HR2105
Accession Number: DP91A0729

back buttonNHIC Home Page